Literature DB >> 24869909

Intravascular device use, management, documentation and complications: a point prevalence survey.

Karen A New1, Joan Webster1, Nicole M Marsh1, Barbara Hewer1.   

Abstract

OBJECTIVE: To examine the use, management, documentation and complications for intravascular devices in cardiac, medical and surgical inpatients.
METHODS: A point prevalence survey was undertaken in a large tertiary hospital in Queensland. Descriptive statistics were used to analyse data.
RESULTS: Of the 327 patients assessed, 192 (58.7%) had one or more devices in situ. Of the 220 devices, 190 (86.4%) were peripheral venous catheters, 25 (11.4%) were peripherally inserted central catheters and five (2.3%) were central venous catheters. Sixty-two of 220 devices (28.2%) were in situ without a clear purpose, whereas 54 (24.7%) had one or more complications, such as redness, pain, tracking, oedema or oozing. There was no documentation on the daily patient care record to indicate that a site assessment had occurred within the past 8h for 25% of the devices in situ.
CONCLUSIONS: The present study identified several problems and highlighted areas for improvement in the management and documentation for intravascular devices. Ongoing education, promoting good clinical practice and reauditing, can be applied to improve the management of devices.

Entities:  

Mesh:

Year:  2014        PMID: 24869909     DOI: 10.1071/AH13111

Source DB:  PubMed          Journal:  Aust Health Rev        ISSN: 0156-5788            Impact factor:   1.990


  9 in total

1.  The flushing procedure in nursing practices: A cross-sectional study with Portuguese and Brazilian nurses.

Authors:  Pedro Parreira; Ricardo Vicente; Rafael A Bernardes; Liliana B Sousa; Beatriz Serambeque; Paulo Costa; Luciene M Braga; Lisete Mónico; Anabela Salgueiro-Oliveira
Journal:  Heliyon       Date:  2020-08-08

2.  Adaptation and validation of pediatric peripheral intravenous catheter insertion and care practices audit tools.

Authors:  Ferika Indarwati; Judy Munday; Samantha Keogh
Journal:  Int J Nurs Sci       Date:  2022-03-15

Review 3.  Infection risks associated with peripheral vascular catheters.

Authors:  Li Zhang; Siyu Cao; Nicole Marsh; Gillian Ray-Barruel; Julie Flynn; Emily Larsen; Claire M Rickard
Journal:  J Infect Prev       Date:  2016-07-06

4.  Postinfusion Phlebitis: Incidence and Risk Factors.

Authors:  Joan Webster; Matthew McGrail; Nicole Marsh; Marianne C Wallis; Gillian Ray-Barruel; Claire M Rickard
Journal:  Nurs Res Pract       Date:  2015-05-14

5.  Risk factors for complications in peripheral intravenous catheters in adults: secondary analysis of a randomized controlled trial.

Authors:  Derdried Athanasio Johann; Mitzy Tannia Reichembach Danski; Stela Adami Vayego; Dulce Aparecida Barbosa; Jolline Lind
Journal:  Rev Lat Am Enfermagem       Date:  2016-11-28

6.  Phlebitis and infiltration: vascular trauma associated with the peripheral venous catheter.

Authors:  Luciene Muniz Braga; Pedro Miguel Parreira; Anabela de Sousa Salgueiro Oliveira; Lisete Dos Santos Mendes Mónico; Cristina Arreguy-Sena; Maria Adriana Henriques
Journal:  Rev Lat Am Enfermagem       Date:  2018-05-17

7.  Varied flushing frequency and volume to prevent peripheral intravenous catheter failure: a pilot, factorial randomised controlled trial in adult medical-surgical hospital patients.

Authors:  Samantha Keogh; Julie Flynn; Nicole Marsh; Gabor Mihala; Karen Davies; Claire Rickard
Journal:  Trials       Date:  2016-07-26       Impact factor: 2.279

8.  Implementing the I-DECIDED clinical decision-making tool for peripheral intravenous catheter assessment and safe removal: protocol for an interrupted time-series study.

Authors:  Gillian Ray-Barruel; Marie Cooke; Marion Mitchell; Vineet Chopra; Claire M Rickard
Journal:  BMJ Open       Date:  2018-06-04       Impact factor: 2.692

9.  A Model of Phlebitis Associated with Peripheral Intravenous Catheters in Orthopedic Inpatients.

Authors:  Sookhee Lee; Kyunghee Kim; Ji-Su Kim
Journal:  Int J Environ Res Public Health       Date:  2019-09-14       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.